4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole

Catalog No. :
ACOOWF606
CAS No. :
1158680-92-2
Molecular Formula :
C19H31BN2O3Si
Molecular Weight :
374.37

IUPAC Name:4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole
IUPAC Name4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole
Molecular FormulaC19H31BN2O3Si
Molecular Weight374.37
SMILESC[Si](CCOCN1N=CC2=C1C=CC=C2B3OC(C)(C)C(C)(C)O3)(C)C
InChI KeyOODJUGQLBCMWMN-UHFFFAOYSA-N
Synonym1H-Indazole, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[[2-(trimethylsilyl)ethoxy]methyl]-;4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[[2-(trimethylsilyl)ethoxy]...;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole
CAS No.1158680-92-2

Synthetic Route by SureRoute

1. ACOOWF606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOOWF606 route product structure diagram
    ACOOWF6061158680-92-2
Inquiry

2. ACOOWF606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRWUM753 route compound structure diagram
    ACRWUM753885618-33-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOOWF606 route product structure diagram
    ACOOWF6061158680-92-2
Inquiry

Comments (0)